More Good News.......hina Health to introduce Type B field lab in Beijing
2011-08-09 08:55 ET - News Release
Mr. Wilson Yao reports
CHINA HEALTH LABS & DIAGNOSTICS LTD. ANNOUNCES NEW PRODUCT LAUNCH FOR POCT DIAGNOSTICS FIELD LABS
China Health Labs & Diagnostics Ltd. will launch its new Type B point-of-care technology (POCT) diagnostic field lab on Aug. 18, 2011, at a major medical equipment conference, the China-HOSPAC 2011, in Beijing, China.
The Type B POCT diagnostic field lab is slated to replace the Type A POCT diagnostic field labs. Since it was launched in 2009, the company has sold over 60 Type A diagnostic field labs to the Chinese military and National Emergency Rescue Team (NERT). The Type B performs all the same diagnostic tests as the Type A, but has been improved along a number of parameters:
Upgraded instruments providing faster and more stable diagnostic tests
Upgraded lab management system with a touch screen user interface
Smaller and lighter, making it easier to transport
Improved frame strength and shell resistance to water and ash
The Type B was developed with the Chinese Military Medical Equipment Research Institute (the "Institute"), based in Tianjin. China Health has established a strong working relationship with the Chinese military, which has led to the cooperative development of POCT products for a wide range of applications. As announced in a press release dated December 8, 2010, China Health signed a three-year research and development agreement with the Institute and with the Third Military Medical University to develop POCT solutions and products for military and rescue diagnostic field lab applications. China Health owns all intellectual property, as well as manufacturing and marketing rights, resulting from this R&D agreement, which includes the improvements made with the Type B.
"The Type A POCT diagnostic field lab is a proven solution, having been deployed effectively in a number of natural disaster rescue missions and military exercises. The Type B was developed based on the operational experience of the Chinese military, our largest customer and R&D partner," said Wilson Yao, CEO of China Health. "While we are the only supplier to the Chinese military and the NERT, we believe that it is important to continually improve our diagnostic solutions to provide increased value to our customers and maintain our competitive advantage. With our proprietary products and early successes in delivering results in the field, we believe that POCT products will be one of our key drivers of revenue and profit growth as we build our business with the Chinese military and the NERT and seek new customers. Our POCT business had strong growth in 2010 and was a key contributor to our strong performance in the first quarter of 2011."
We seek Safe Harbor.
Top